Ixekizumab Survival in Heavily Pretreated Patients with Psoriasis: A Two-year Single-centre Retrospective Study

The long-term effect of intra-anti-interleukin-17-class switch on drug survival is unclear. The aim of this study was to evaluate the efficacy and long-term survival of ixekizumab in bio-experienced psoriatic patients with and without previous exposure to anti-interleukin-17 treatment. Retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: SHERMAN, Shany, ZLOCZOWER, Ory, NOYMAN, Yehonatan, AMITAY-LAISH, Iris, HODAK, Emmilia, PAVLOVSKY, Lev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society for Publication of Acta Dermato-Venereologica 2020
Materias:
Clinical Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309699/
https://www.ncbi.nlm.nih.gov/pubmed/33283248
http://dx.doi.org/10.2340/00015555-3714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309699/
https://www.ncbi.nlm.nih.gov/pubmed/33283248
http://dx.doi.org/10.2340/00015555-3714

Ejemplares similares